Neurol. praxi. 2014;15(2):77-82

Magnetic resonance and sclerosis multiplex

MUDr. Monika Daňová1,2, MUDr. Víťazoslav Belan, PhD.3
1 ProMagnet, s. r. o., magnetická rezonancia, FNsP J. A. Reimana, Prešov

Magnetic resonance (MR) imaging started to be in exacting diagnostic process of multiple scleroris (MS) an important supporting examination method that in 2001 was included into diagnostic criteria (McDonald criteria SM 2001). Following these criteria passed a modification in 2005 and 2010 with an aim to increase their sensitivity at preserving their specificity. MR is at present the most used biomarker in the process of diagnosis, at determination of prognosis and monitoring of disease progression, using conventional and non conventional techniques. Into conventional techniques belong T1 weighted images without or with administration of a contrast medium, T2 weighted images (T2vo) from which postprocessing at using of soft cuttings, the volume of lesions can be determined (e. g. lesion load) for watching of inflammation or at neurodegeneration turn, at patient we can measure the brain atrophy. The non conventional techniques are exercised in experimental works, that examine the pathologic process in MS eventually are applied in diagnosis and differential diagnosis.

Keywords: magnetic resonance, sclerosis multiplex, diagnostic criteria, clinically isolated syndrome

Published: May 10, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Daňová M, Belan V. Magnetic resonance and sclerosis multiplex. Neurol. praxi. 2014;15(2):77-82.
Download citation

References

  1. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997; 120: 2059-2069. Go to original source... Go to PubMed...
  2. Daňová M, Klímová E, Belan V. MR kritéria sclerosis multiplex - McDonald 2010, Slov. radiol. 2012; 19(2): 17-21.
  3. Fazekas F, Offenbacher H, Fuchs S, Schmidt R, Niederkorn K, Horner S, Lechner H. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988; 38: 1822-1825. Go to original source... Go to PubMed...
  4. Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, Comi G, Gallo P. Intracortical lesions. Relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010; 75: 1988-1994. Go to original source... Go to PubMed...
  5. Filippi M, Rocca MA, De Stefano N, Enzinger CH, Fisher E, Horsfiel M, Inglese M, Pelletier D, Comi G. Magnetic Resonance Techniques in Mutiple Sclerosis. Arch Neurol. 2011;68(12): 1514-1520. Go to original source... Go to PubMed...
  6. Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, Thompson AJ, Miller DH. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008; 131: 808-817. Go to original source... Go to PubMed...
  7. Ge Y. Multiple Sclerosis: The Role of MR Imaging. Am J Neuroradiol. June 2006; 27: 1165-1176.
  8. Havrdová E. Roztroušená skleróza. Cesk Slov Neurol N. 2008; 71/104(2): 121-132.
  9. Horáková D, Vaněčková M. Význam magnetické rezonance ve sledování aktivity roztroušené sklerózy - pohled klinického neurologa. Neurol. praxi. 2012; 13(6): 320-324.
  10. Klímová E. Poruchy kognitívnych funkcií u pacientov so sclerosis multiplex. Via practica. 2008; 5(S4): 36-41.
  11. Lóvblad KO, Anzalone N, Dórfler A, Essig M, Hurwitz B, Kappos L, Lee SK, Filippi M. MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice. Am J Neuroradiology. 2010; 31: 983-989. Go to original source... Go to PubMed...
  12. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W,Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic Diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50: 121-127. Go to original source... Go to PubMed...
  13. Minneboo A, Jasperse B, Barkhof F, Uitdehaag BMJ, Knol DL, de Groot V, Polman CH, Castelijns JA. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters. J Neurol Neurosurg Psychiatry. 2012; 79: 917-923. Go to original source... Go to PubMed...
  14. Montalban X, Tintore M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A,Yousry T, Rovira A, Miller DH. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010; 74: 427-434. Go to original source... Go to PubMed...
  15. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 1988; 38: 180-185. Go to original source... Go to PubMed...
  16. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P,Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69: 292-302. Go to original source... Go to PubMed...
  17. Polman CH, Reingold SC, Edan G, M Filippi, Hartung HP, Kappos L,Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revision to the, ,McDonald Criteria". Ann Neurol. 2005; 58: 840-846. Go to original source... Go to PubMed...
  18. Rovira A, Swanton JK, Tintoré M, Huerga E, Barkhof F, Filippi M, Frederiksen JL, Langkilde A, Miszkiel K, Polman C, Rovaris M, Sastre-Garriga J, Miller D, Montalban X. A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis. Arch Neurol. 2009; 66(5): 587-592. Go to original source... Go to PubMed...
  19. Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M, Huerga E, Miszkiel KA, Plant GT, Polman C, Rovaris M, Thompson AJ, Montalban X, Miller DH. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007; 6: 677-686. Go to original source... Go to PubMed...
  20. Vaněčková M, Seidl Z, Krásenský J, Horáková D, Havrdová E, Němcová J, Daneš. Naše zkušenosti s MR monitorováním pacientů s roztroušenou sklerózou v klinické praxi. Cesk Slov Neurol N. 2010; 73/106: 716-720.
  21. Wattjes MP, Barkhof F. High field MRI in the diagnosis of multiple sclerosis: high field -high yield? Neuroradiology. 2009; 51: 279-292. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.